Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Rigel Pharmaceuticals, Inc. will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, highlighting its focus on hematologic disorders and cancer [1]. Company Overview - Rigel Pharmaceuticals, Inc. is a biotechnology company established in 1996, based in South San Francisco, California, dedicated to discovering and developing novel therapies for patients with hematologic disorders and cancer [3]. - The company is publicly traded on Nasdaq under the ticker symbol RIGL [3]. Event Details - The presentation will be led by Raul Rodriguez, the president and CEO of Rigel Pharmaceuticals, scheduled for 3:00 p.m. PT (6:00 p.m. ET) [1]. - Investors can access the live webcast or archived recording through the Investor Relations section of Rigel's website [2].